foxo4-dri senolytic peptide study 2017 cell alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Buy FOXO4-DRI | Exceptional 99%+
Buy FOXO4 DRI Exceptional 99%+ Purity Third Party COA Included FOXO4 an overview ScienceDirect Topics Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17





